| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/31/2004 | EP1401484A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 03/31/2004 | EP1401483A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401469A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 03/31/2004 | EP1401461A2 Selective cox-2 inhibition from edible plant extracts |
| 03/31/2004 | EP1401460A2 Selective cox-2 inhibition from plant extracts |
| 03/31/2004 | EP1401452A1 Beta-hydroxyamine derivatives useful in the treatment of alzheimer's disease |
| 03/31/2004 | EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone |
| 03/31/2004 | EP1401449A1 Tetracyclic compounds as pde5-inhibitors |
| 03/31/2004 | EP1401441A2 Allosteric adenosine receptor modulators |
| 03/31/2004 | EP1401439A1 Use of bicyclo compounds for treating alzheimer's disease |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1401432A2 Imidazole derivatives for modulating sodium channels |
| 03/31/2004 | EP1401431A2 Human growth hormone antagonists |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP1401424A1 Carbamate compounds for use in preventing or treating psychotic disorders |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1401415A2 Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| 03/31/2004 | EP1401414A2 Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401409A2 Stable powder inhalation dosage formulation |
| 03/31/2004 | EP1401408A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot |
| 03/31/2004 | EP1401398A1 PHARMACEUTICAL FORMULATION FOR THE EFFICIENT ADMINISTRATION OF APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND THEIR DERIVATIVES AND PRO-DRUGS THEREOF |
| 03/31/2004 | EP1401393A2 No-synthase inhibitor and use thereof |
| 03/31/2004 | EP1401375A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling |
| 03/31/2004 | EP1282620B1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 03/31/2004 | EP1250156A4 Method for nucleic acid transfection of cells |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1232144B1 Novel il-8 receptor antagonists |
| 03/31/2004 | EP1181318B1 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/31/2004 | EP1181294B1 Novel derivatives and analogues of galanthamin |
| 03/31/2004 | EP1171132B1 Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
| 03/31/2004 | EP1135360B1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 03/31/2004 | EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 03/31/2004 | EP0994705B1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 03/31/2004 | EP0977578B1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | EP0808316B1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines |
| 03/31/2004 | EP0781766B1 Heterocyclic derivative and medicine |
| 03/31/2004 | EP0755249B1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486321A Indole derivative and its medicine application |
| 03/31/2004 | CN1486314A Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 03/31/2004 | CN1486308A Piperazinylcarbonylquinolines and -isoquinolines |
| 03/31/2004 | CN1486301A 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/31/2004 | CN1486298A Prodrugs of excitatory amino acids |
| 03/31/2004 | CN1486205A Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 03/31/2004 | CN1486196A Complex of modafinil and cyclodextrin |
| 03/31/2004 | CN1486195A Methods for reducing chronic stress in mammals |
| 03/31/2004 | CN1486192A Binding domain-immunoglobulin fusion proteins |
| 03/31/2004 | CN1486184A Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 03/31/2004 | CN1486183A Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 03/31/2004 | CN1486180A Methods for treating neuropsychiatric disorders with NMDA receptor antagonists |
| 03/31/2004 | CN1485341A Method for modifying growth factors by recombined technology |
| 03/31/2004 | CN1485077A Sapid invigorating yang five-recouping capsule and the preparation thereof |
| 03/31/2004 | CN1485059A Biologic active factor for smoking smoking, and smoking- quitting toothpaste containing the active factor |
| 03/31/2004 | CN1485039A Antalgic, drug addiction-stopping medication and its preparation method |
| 03/31/2004 | CN1485036A Compound demerol formulation |
| 03/31/2004 | CN1485007A Delicately fragrant nerve-soothing pillow |
| 03/31/2004 | CN1143858C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
| 03/31/2004 | CN1143848C 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 03/31/2004 | CN1143688C Triacetin as transdermal permeation enhancer |
| 03/31/2004 | CN1143686C Chinese traditional medicine for alcoholism relieving |
| 03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 03/31/2004 | CN1143674C Refractory vasculitis therapeutic agent |
| 03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713604 Synthetic cyclic peptides that inhibit that binding |
| 03/30/2004 | US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/30/2004 | US6713499 Adenosine receptor agonist |
| 03/30/2004 | US6713497 Reducing side effects from excess gamma amino butyric acid (gaba) in central nervous system |
| 03/30/2004 | US6713493 Of neurological diseases involving attack of the pyramidal pathway such as: amyotrophic lateral sclerosis, progressive spinal muscular atrophy, infantile muscular atrophy, primary lateral sclerosis and cerebrovascular accident |
| 03/30/2004 | US6713491 For use as medicine for antagonising the effects of excitatory amino acids upon the nmda receptor complex |
| 03/30/2004 | US6713490 6-(2-(4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl)-1-hydroxy -ethyl)-3,4-dihydro-2(1h)-quinolinone; reduced inhibitory activity at herg (human ether-a-go-go related gene) potassium channel |
| 03/30/2004 | US6713488 Neutral antagonists and use thereof in treating drug abuse |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713470 Method of treatment |
| 03/30/2004 | US6713468 Methods of using thiazolobenzoheterocycles |
| 03/30/2004 | US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713450 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 03/30/2004 | US6713443 Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications |
| 03/30/2004 | US6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device |
| 03/30/2004 | US6713276 Modulation of Aβ levels by β-secretase BACE2 |
| 03/30/2004 | US6713247 Human CNS cell lines and methods of use therefor |
| 03/30/2004 | US6713097 Use of a preparation of cimicifuga racemosa |
| 03/30/2004 | US6713091 With licorice; beverage for curing a hangover, source of dietary fiber |
| 03/30/2004 | US6713090 Apparatus and method for preparing microparticles |
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/30/2004 | US6713048 Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use |